Tocilizumab
CHF 8.36
Auf Lager
SKU
RU4S0C4PVU8
1 Verfügbar Details
Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Tocilizumab (INN, or atlizumab, developed by Hoffmann La Roche and Chugai under the trade names Actemra and RoActemra) is a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R) used as an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis. Interleukin 6 is a cytokine that plays an important role in immune response and is implicated in the pathogenesis of many diseases, such as autoimmune diseases, multiple myeloma and prostate cancer.
30 Tage Rückgaberecht
GarantieWeitere Informationen
- Allgemeine Informationen
- GTIN 09786130899479
- Genre Medizin
- Editor Lambert M. Surhone, Miriam T. Timpledon, Susan F. Marseken
- Anzahl Seiten 88
- Herausgeber Betascript Publishing
- Größe H5mm x B220mm x T150mm
- EAN 9786130899479
- Format Fachbuch
- Titel Tocilizumab
- Gewicht 150g
Bewertungen
Schreiben Sie eine Bewertung